Oats and celiac disease

Celaic disease is an immune-mediated disorder of the small bowel that is triggered by exposure to gluten. Symptoms of celiac disease include chronic diarrhea, weight loss, abdominal distention. The only effective treatment is life-long gluten free diet.

There is increasing clinical data supporting the view that oats can be included in a gluten-free diet. The inclusion of oats into diet would make it possible to diversify the diet of celiac patients by providing cereal character and high fiber content foods. However, it seems evident that majority of oats available commercially is its contamination with wheat, barley or other prolamin containing cereals. Active efforts have been made to develop ‘clean oat’ production chain that is certified to be free of gluten containing cereals.

Also children with celiac disease have been reported to tolerate uncontaminated oats. Children are very pleased to use oat containing products, as oat delivers a typical cereal character into food products and enables the use of typical cereal foods like bakery products, porridges and snacks. The development of whole-oat baking technology further improves the quality and enjoyability of traditional-style soft breads. A selection of oat breads for celiac patients is already commercially available.



Anderson, R.P., Wieser, H. (2006) Medical applications of gluten-composition knowledge. Gliadin and Glutenin, pp. 387-409.

Anderson, R.P., Degano, P., Godkin, A.J., Jewell, D.P., Hill, A.V.S. (2000) In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope. Nature Medicine 6, pp. 337-345.

Ciacci, C., Cirillo, M., Cavallaro, R., Mazzacca, G. (2002) Long-term follow-up of celiac adults on gluten-free diet: Prevalence and correlates of intestinal damage. Digestion 66, pp. 178-185.

Collin, P., Thorell, L., Kaukinen, K., Maki, M. (2004) The safe threshold for gluten contamination in gluten-free products. Can trace amounts be accepted in the treatment of celiac disease? Alimentary Pharmacology and Therapeutics 19, pp. 1277-1283.

Dahele, A., Ghosh, S. (2001) Vitamin B12 deficiency in untreated celiac disease. American Journal of Gastroenterology 96, pp. 745-750.

Faulkner-Hogg, K.B., Selby, W.S., Loblay, R.H. (1999) Dietary analysis in symptomatic patients with coeliac disease on a gluten-free diet: the role of trace amounts of gluten and non-gluten food intolerances. Scandinavian journal of gastroenterology 34, pp. 784-789.

Gibert, A., Espadaler, M., Angel Canela, M., Sanchez, A., Vaque, C., Rafecas, M. (2006) Consumption of gluten-free products: should the threshold value for trace amounts of gluten be at 20, 100 or 200 ppm? European journal of gastroenterology & hepatology 18, pp. 1187-1195.

Goodman, R.E., Hefle, S.L. (2005) Gaining perspective on the allergenicity assessment of genetically modified food crops. Expert Review of Clinical Immunology 1, pp. 561-578.

Hallert, C., Grant, C., Grehn, S., Graennoe, C., Hulten, S., Midhagen, G., Stroem, M., Svensson, H., Valdimarsson, T. (2002) Evidence of poor vitamin status in coeliac patients on a gluten-free diet for 10 years. Alimentary Pharmacology and Therapeutics 16, pp. 1333-1339.

Holm K, Mäki M, Vuolteenaho N, Mustalahti K, Ashorn M, Ruuska T, et al. Oats in the treatment of childhood coeliac disease: A 2-year controlled trial and a long-term clinical follow-up study. Aliment.Pharmacol.Ther. 2006;23(10):1463-1472.

Holtmeier, W. (2006) Treatment and management of celiac disease. Zeitschrift fuer Gastroenterologie 44, pp. 1167-1175.

Lee, L.A., Burks, A.W. (2006) Food allergies: prevalence, molecular characterization, and treatment / prevention strategies. Annual Review of Nutrition 26, pp. 539-565.

Leiss, O. (2003) Pitfalls and problems of a gluten-free diet: Are oats harmful to patients with coeliac disease? Aktuelle Ernaehrungsmedizin 28, pp. 385-395.

Maiuri, L., Ciacci, C., Ricciardelli, I., Vacca, L., Raia, V., Auricchio, S., Picard, J., Osman, M., Quaratino, S., Londei, M. (2003) Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease. Lancet, Vol. 362, No. 9377, pp. 30-37.

Narasaka, S., Endo, Y., Fu, Z., Moriyama, M., Arai, S., Abe, K., Kato, H. (2006) Safety evaluation of hypoallergenic wheat flour by using a DNA microarray. Bioscience, biotechnology, and biochemistry 70, pp. 1464-1470.

Peräaho, M., Kaukinen, K., Paasikivi, K., Sievänen, H., Lohiniemi, S., Mäki, M., Collin, P. (2003) Wheat-starch-based gluten-free products in the treatment of newly detected coeliac disease: prospective and randomized study. Alimentary Pharmacology and Therapeutics 17, pp. 587-594.

Sjöström, H., Lundin, K.E.A., Molberg, O., Korner, R., McAdam, S.N., Anthonsen, D., Quarsten, H., Noren, O., Roepstorff, P., Thorsby, E., Sollid, L.M. (1998) Identification of a gliadin T-cell epitope in celiac disease: general importance of gliadin deamidation for intestinal T-cell recognition. Scandinavian journal of immunology 48, pp. 111-115.

Skerritt, J.H., Hill, A.S. (1992). How "free" is "gluten free"? Relationship between Kjeldahl nitrogen values and gluten protein content for wheat starches. Cereal Chemistry 69, pp. 110-112.

Storsrud, S., Hulthen, L.R., Lenner, R.A. (2003) Beneficial effects of oats in the gluten-free diet of adults with special reference to nutrient status, symptoms and subjective experiences. British Journal of Nutrition 90, pp. 101-107.

Størsrud S, Malmheden Yman I, Lenner RA. Gluten contamination in oat products and products naturally free from gluten. Eur.Food Res.Technol. 2003;217(6):481-485.

Thompson, T. (1999) Thiamin, riboflavin, and niacin contents of the gluten-free diet: Is there cause for concern? Journal of the American Dietetic Association 99, pp. 858-862.

Valdes, I., Garcia, E., Llorente, M., Mendez, E. (2003) Innovative approach to low-level gluten determination in foods using a novel sandwich enzyme-linked immunosorbent assay protocol. European journal of gastroenterology & hepatology 15, pp. 465-474.

van Heel, D.A., West, J. (2006) Recent advances in coeliac disease. Gut 55, pp. 1037-1046.